首页 > 最新文献

Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten最新文献

英文 中文
[Adenomas and carcinomas of the small intestine in familial polyposis and Gardner syndrome--analysis of a literature survey]. 【家族性息肉病和Gardner综合征中的小肠腺瘤和癌——文献调查分析】。
F Sellner

An analysis of 70 case records from the literature of patients with familial polyposis or Gardner syndrome and adenomas or carcinomas of the small bowel demonstrated that there is no difference between the neoplasms of the small bowel in familial polyposis or in Gardner syndrome. Between the adenomas and the carcinomas of the small bowel it was possible to show, that there exists a similar close relation as in the large intestine. In some carcinomas of the small bowel rests of adenomas can be observed. The peak incidence of small bowel adenomas is more than a decade earlier than that of carcinomas. The distribution of adenomas in the small bowel is quite similar to that of carcinomas. Therefore it can be supposed, that the significance of familial polyposis coli and Gardner syndrome for the importance of an adenoma-carcinoma-sequence in the large bowel is also existing in the small bowel.

对70例家族性息肉病或Gardner综合征与小肠腺瘤或癌的文献记录分析表明,家族性息肉病或Gardner综合征的小肠肿瘤没有区别。在腺瘤和小肠癌之间有可能显示,它们之间存在着与大肠相似的密切关系。在一些小肠癌中可以观察到腺瘤的残余。小肠腺瘤的发病高峰比癌早10年以上。小肠腺瘤的分布与癌的分布十分相似。因此可以推测,家族性大肠息肉病和Gardner综合征对大肠腺瘤-癌-序列的重要性的意义同样存在于小肠中。
{"title":"[Adenomas and carcinomas of the small intestine in familial polyposis and Gardner syndrome--analysis of a literature survey].","authors":"F Sellner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>An analysis of 70 case records from the literature of patients with familial polyposis or Gardner syndrome and adenomas or carcinomas of the small bowel demonstrated that there is no difference between the neoplasms of the small bowel in familial polyposis or in Gardner syndrome. Between the adenomas and the carcinomas of the small bowel it was possible to show, that there exists a similar close relation as in the large intestine. In some carcinomas of the small bowel rests of adenomas can be observed. The peak incidence of small bowel adenomas is more than a decade earlier than that of carcinomas. The distribution of adenomas in the small bowel is quite similar to that of carcinomas. Therefore it can be supposed, that the significance of familial polyposis coli and Gardner syndrome for the importance of an adenoma-carcinoma-sequence in the large bowel is also existing in the small bowel.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 5","pages":"287-93"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14159605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hepatitis B risk in dental personnel]. [牙科人员的乙型肝炎风险]。
J Fischer, J D Fengler, R Baumgarten, R Markus, H Richter

Dependent on the profession, medical personal is at different risk of hepatitis B infection. 505 staff members of 48 Berlin dental clinics were investigated for hepatitis B virus markers and demonstrated a significantly lower prevalence of HBsAg and its antibody than other hospital personal: anti-HBs positivity (EIA) was found in only 5.5 per cent of them (dental technicians: 1.6%, dental assistants: 3.8%, dentists: 8.0%). We conclude that in the GDR dental staff is not at higher risk of hepatitis B infection than other non-risk medical personal. Legal aspects of insurance and measures for hygienic prevention in dental practice are discussed.

医务人员感染乙型肝炎的风险因职业不同而不同。对柏林48家牙科诊所的505名工作人员进行了乙型肝炎病毒标志物调查,结果显示HBsAg及其抗体的流行率明显低于其他医院人员:仅5.5%的人(牙科技师:1.6%,牙科助理:3.8%,牙医:8.0%)呈抗乙肝病毒阳性(EIA)。我们得出结论,在德意志民主共和国,牙科工作人员感染乙型肝炎的风险并不比其他无风险的医务人员高。讨论了保险的法律问题和牙科卫生预防措施。
{"title":"[Hepatitis B risk in dental personnel].","authors":"J Fischer,&nbsp;J D Fengler,&nbsp;R Baumgarten,&nbsp;R Markus,&nbsp;H Richter","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Dependent on the profession, medical personal is at different risk of hepatitis B infection. 505 staff members of 48 Berlin dental clinics were investigated for hepatitis B virus markers and demonstrated a significantly lower prevalence of HBsAg and its antibody than other hospital personal: anti-HBs positivity (EIA) was found in only 5.5 per cent of them (dental technicians: 1.6%, dental assistants: 3.8%, dentists: 8.0%). We conclude that in the GDR dental staff is not at higher risk of hepatitis B infection than other non-risk medical personal. Legal aspects of insurance and measures for hygienic prevention in dental practice are discussed.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 4","pages":"223-8"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14921372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study]. [秋水仙碱治疗纤维化肝病——一项随机双盲研究报告]。
M Reinhardt, D Jorke, G Jahn, B Krombholz, A Müller, G Machnik, H Kunath

It is reported on results of a double blind study of colchicine therapy in fibrotic liver diseases over a period of three years. The study includes 74 probands; 37 of them had been treated after randomization for five days a week with 4 X 0,25 mg/d colchicine, 37 with placebo. 53 probands attained the 12th month of treatment, 43 of them 24th, 24 probands were in the study for 36 months. 3 diagnoses groups had been formed with regard to the histological grades of fibrosis: chronic hepatitis (without structural transformation); structural liver transformation/moderate liver cirrhosis; severe liver cirrhosis. In 38 cases the disease was caused by alcohol. 45 data had been studied (clinical results, paraclinical data concerning hepatological diagnostic and connective tissue metabolism and morphologic data). The biometric evaluation was carried out with the stage variant analysis by Friedman. Rebiopsies have been carried out in 40 probands after 1 year, in 4 probands after 2 years. 4 data (Serumalbumine, Gamma-GT, ALAT, KP) showed significant changes in the colchicine-group as well as in the placebo-group. In both therapy groups the morphologic supervisions of the fibrosis grades (rebiopsies) showed improvements, no changes, and deterioration about in the same frequency. In this study there was no effectiveness of colchicine on the course of fibrotic liver diseases to be stated. Concerning the contradictions in the recent literature and probable the insufficient colchicine dose, the authors recommend further studies on colchicine therapy in liver diseases with incipient i.e. reversible fibrosis.

本文报道了一项为期三年的秋水仙碱治疗纤维化肝病的双盲研究结果。本研究包括74个先证者;其中37人在随机分组后接受了每周5天的4 × 0,25 mg/d秋水仙碱治疗,37人接受安慰剂治疗。53名先证者治疗12个月,其中43名治疗24个月,24名先证者治疗36个月。根据纤维化的组织学分级形成3个诊断组:慢性肝炎(无结构转化);结构性肝转化/中度肝硬化;严重肝硬化。其中38例是由酒精引起的。研究了45项数据(临床结果、肝脏学诊断和结缔组织代谢和形态学数据)。生物特征评估采用Friedman的阶段变异分析。40名先证者在1年后进行了再活检,4名先证者在2年后进行了再活检。4项数据(血清白蛋白、γ - gt、ALAT、KP)显示秋水仙碱组和安慰剂组有显著变化。在两个治疗组中,纤维化等级的形态学监测(再活检)显示改善,无变化,恶化的频率大致相同。在这项研究中,秋水仙碱对纤维化肝病的病程没有疗效。鉴于近期文献的矛盾和秋水仙碱剂量可能不足,作者建议进一步研究秋水仙碱治疗早期即可逆性纤维化肝脏疾病。
{"title":"[Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study].","authors":"M Reinhardt,&nbsp;D Jorke,&nbsp;G Jahn,&nbsp;B Krombholz,&nbsp;A Müller,&nbsp;G Machnik,&nbsp;H Kunath","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>It is reported on results of a double blind study of colchicine therapy in fibrotic liver diseases over a period of three years. The study includes 74 probands; 37 of them had been treated after randomization for five days a week with 4 X 0,25 mg/d colchicine, 37 with placebo. 53 probands attained the 12th month of treatment, 43 of them 24th, 24 probands were in the study for 36 months. 3 diagnoses groups had been formed with regard to the histological grades of fibrosis: chronic hepatitis (without structural transformation); structural liver transformation/moderate liver cirrhosis; severe liver cirrhosis. In 38 cases the disease was caused by alcohol. 45 data had been studied (clinical results, paraclinical data concerning hepatological diagnostic and connective tissue metabolism and morphologic data). The biometric evaluation was carried out with the stage variant analysis by Friedman. Rebiopsies have been carried out in 40 probands after 1 year, in 4 probands after 2 years. 4 data (Serumalbumine, Gamma-GT, ALAT, KP) showed significant changes in the colchicine-group as well as in the placebo-group. In both therapy groups the morphologic supervisions of the fibrosis grades (rebiopsies) showed improvements, no changes, and deterioration about in the same frequency. In this study there was no effectiveness of colchicine on the course of fibrotic liver diseases to be stated. Concerning the contradictions in the recent literature and probable the insufficient colchicine dose, the authors recommend further studies on colchicine therapy in liver diseases with incipient i.e. reversible fibrosis.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 5","pages":"257-75"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14665676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pure human pancreatic juice. Methodologic aspects of pancreatic juice collection and interpretation of findings]. 纯人类胰液。胰液收集的方法学方面和结果的解释]。
S Liebe, J Weber, E Siegmund, L Bendel, R Arendt

A procedure to collect pure pancreatic juice endoscopically is described which allows an instant estimation of the protein content of the secretion by measuring its absorption at 280 nm. By this the kinetics of protein secretion can already be read from a curve during the collecting procedure, thus avoiding a multitude of small fractions otherwise necessary. Timing and size of the samples are adjusted individually according to the course of protein secretion and not to a rigid regimen. The method described is especially apt to investigations of pancreatic proteins and substances the secretion of which parallels that of protein; e. g. trypsinogen, calcium and zinc, however not sodium and potassium.

本文描述了一种在内窥镜下收集纯胰液的方法,通过测量其在280 nm处的吸收,可以即时估计分泌物的蛋白质含量。通过这种方法,在收集过程中已经可以从曲线上读取蛋白质分泌的动力学,从而避免了大量的小分数。样品的时间和大小根据蛋白质分泌的过程单独调整,而不是严格的方案。所描述的方法特别适用于胰腺蛋白质和分泌与蛋白质相似的物质的研究;比如胰蛋白酶原,钙和锌,而不是钠和钾。
{"title":"[Pure human pancreatic juice. Methodologic aspects of pancreatic juice collection and interpretation of findings].","authors":"S Liebe,&nbsp;J Weber,&nbsp;E Siegmund,&nbsp;L Bendel,&nbsp;R Arendt","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A procedure to collect pure pancreatic juice endoscopically is described which allows an instant estimation of the protein content of the secretion by measuring its absorption at 280 nm. By this the kinetics of protein secretion can already be read from a curve during the collecting procedure, thus avoiding a multitude of small fractions otherwise necessary. Timing and size of the samples are adjusted individually according to the course of protein secretion and not to a rigid regimen. The method described is especially apt to investigations of pancreatic proteins and substances the secretion of which parallels that of protein; e. g. trypsinogen, calcium and zinc, however not sodium and potassium.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 1","pages":"45-52"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14840304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The development of endoscopic papillotomy in East Germany]. 【内镜下乳头切开术在东德的发展】。
K U Schentke, H J Schulz

Unlabelled: Up to the middle of 1985 a survey of endoscopic papillotomy (EPT) had been carried out in the GDR resulting in 3124 patients from 8 centers.

Indications: choledocholithiasis 90.6% (13.1% with a T-drain, 16.2% with a gallbladder in situ); papillary stenosis 4.4%; tumors of the papilla 2.2%; other indications 2.2%. The common bile duct got free of stones in 89.3% of 2210 documented cases after successful EPT. In comparison to former results in 1982, 1983 and 1984 (cumulated data) the technical success rate of EPT rose slightly, but steadily to 95.3%, and the complication rate fell to 5.8%. Bleeding was the most common complication followed by cholangitis, pancreatitis, basket impaction and perforation. 30 patients (0.96%) died due to complications, 14 with pancreatitis, 7 cholangitis, 7 bleeding, 2 perforation.

未标记:到1985年中期,在德意志民主共和国进行了一项内镜乳头切开术(EPT)的调查,共有来自8个中心的3124名患者。适应症:胆总管结石90.6% (t型引流13.1%,原位胆囊16.2%);乳头状狭窄4.4%;乳头瘤2.2%;其他指标2.2%。2210例成功行EPT后,总胆管结石发生率为89.3%。与1982年、1983年和1984年(累积数据)相比,EPT的技术成功率略有上升,但稳步上升至95.3%,并发症发生率下降至5.8%。出血是最常见的并发症,其次是胆管炎、胰腺炎、肠梗阻和穿孔。并发症死亡30例(0.96%),其中胰腺炎14例,胆管炎7例,出血7例,穿孔2例。
{"title":"[The development of endoscopic papillotomy in East Germany].","authors":"K U Schentke,&nbsp;H J Schulz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Unlabelled: </strong>Up to the middle of 1985 a survey of endoscopic papillotomy (EPT) had been carried out in the GDR resulting in 3124 patients from 8 centers.</p><p><strong>Indications: </strong>choledocholithiasis 90.6% (13.1% with a T-drain, 16.2% with a gallbladder in situ); papillary stenosis 4.4%; tumors of the papilla 2.2%; other indications 2.2%. The common bile duct got free of stones in 89.3% of 2210 documented cases after successful EPT. In comparison to former results in 1982, 1983 and 1984 (cumulated data) the technical success rate of EPT rose slightly, but steadily to 95.3%, and the complication rate fell to 5.8%. Bleeding was the most common complication followed by cholangitis, pancreatitis, basket impaction and perforation. 30 patients (0.96%) died due to complications, 14 with pancreatitis, 7 cholangitis, 7 bleeding, 2 perforation.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 4","pages":"217-22"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14920615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome. 肝动脉栓塞——治疗恶性类癌综合征的新途径。
G Jermendy, A Kónya, P Kárpáti

A transcatheter embolisation was carried out for treatment of a patient suffering from hepatic metastases of a malignant carcinoid tumour. Recurrent and very severe carcinoid symptoms could be observed; a bronchial carcinoid supposingly the primary tumour without characteristic symptoms was removed six years before. The carcinoid symptoms became resistant to pharmacological agents and finally ended in life-threatening clinical complications. The transcatheter hepatic artery embolisation was successfully performed and repeated three months later. After embolisation relief of carcinoid symptom and a significant decrease in 5-hydroxyindole acetic acid (5-HIAA) urinary excretion lasting for eight months could be observed. There were no serious complications with adequate pharmacological cover, however, a transient fever, leucocytosis, abdominal pain and an increase in serum transaminase activities occurred after the procedure. The transcatheter hepatic artery embolisation should be a method of choice for treatment of patients with carcinoid metastases producing severe carcinoid symptoms resistant to pharmacological agents.

经导管栓塞治疗的病人患有肝转移的恶性类癌肿瘤。可观察到复发性和非常严重的类癌症状;支气管类癌,原发肿瘤,无特征性症状,于六年前切除。类癌症状对药物产生耐药性,最终导致危及生命的临床并发症。经肝动脉栓塞成功,3个月后再次行肝动脉栓塞术。栓塞后类癌症状缓解,5-羟基吲哚乙酸(5-HIAA)尿排泄量显著下降,持续8个月。没有严重的并发症,有足够的药理学保护,然而,一过性发烧,白细胞增多,腹痛和血清转氨酶活性增加发生在手术后。经导管肝动脉栓塞应该是治疗类癌转移患者的一种选择方法,这些患者产生了严重的类癌症状,对药物有耐药性。
{"title":"Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.","authors":"G Jermendy,&nbsp;A Kónya,&nbsp;P Kárpáti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A transcatheter embolisation was carried out for treatment of a patient suffering from hepatic metastases of a malignant carcinoid tumour. Recurrent and very severe carcinoid symptoms could be observed; a bronchial carcinoid supposingly the primary tumour without characteristic symptoms was removed six years before. The carcinoid symptoms became resistant to pharmacological agents and finally ended in life-threatening clinical complications. The transcatheter hepatic artery embolisation was successfully performed and repeated three months later. After embolisation relief of carcinoid symptom and a significant decrease in 5-hydroxyindole acetic acid (5-HIAA) urinary excretion lasting for eight months could be observed. There were no serious complications with adequate pharmacological cover, however, a transient fever, leucocytosis, abdominal pain and an increase in serum transaminase activities occurred after the procedure. The transcatheter hepatic artery embolisation should be a method of choice for treatment of patients with carcinoid metastases producing severe carcinoid symptoms resistant to pharmacological agents.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 2","pages":"130-6"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13572347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Microbial pathogenesis of Whipple's disease]. [惠普尔病的微生物发病机制]。
H Bernhardt, M Knoke, G Lorenz, R Möllmann

In a case of Whipple's disease with electron microscopic demonstration of rod-shaped bacteria we could isolate Propionibacterium acnes (former name: Corynebacterium anaerobium), Actinomyces, and Lactobacillus from duodenal biopsies by the aid of modern anaerobic culture technique. Simultaneously we found a dysbiosis (increase of anaerobic coca and anaerobes) in du odenal juice. After antibiotic treatment Propionibacterium and Lactobacillus disappeared and an other type of dysbiosis (appearance of Bacteroides) was to be seen. In discussion is a change of immunologic state and following disturbed regulation of microbial colonization in the small bowel of patients with Whipple's disease.

在惠普尔氏病的病例中,电镜显示杆状细菌,我们可以通过现代厌氧培养技术从十二指肠活检中分离出痤疮丙酸杆菌(原名:厌氧棒状杆菌)、放线菌和乳杆菌。同时,我们发现了一种生态失调(厌氧古柯和厌氧菌的增加),在杜登汁。抗生素治疗后,丙酸杆菌和乳酸杆菌消失,另一种类型的生态失调(出现拟杆菌)。讨论惠普尔病患者小肠微生物定植紊乱后免疫状态的变化。
{"title":"[Microbial pathogenesis of Whipple's disease].","authors":"H Bernhardt,&nbsp;M Knoke,&nbsp;G Lorenz,&nbsp;R Möllmann","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In a case of Whipple's disease with electron microscopic demonstration of rod-shaped bacteria we could isolate Propionibacterium acnes (former name: Corynebacterium anaerobium), Actinomyces, and Lactobacillus from duodenal biopsies by the aid of modern anaerobic culture technique. Simultaneously we found a dysbiosis (increase of anaerobic coca and anaerobes) in du odenal juice. After antibiotic treatment Propionibacterium and Lactobacillus disappeared and an other type of dysbiosis (appearance of Bacteroides) was to be seen. In discussion is a change of immunologic state and following disturbed regulation of microbial colonization in the small bowel of patients with Whipple's disease.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 1","pages":"53-61"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13573129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Modification of orocecal transit time of salazosulfapyridine by atropine and metoclopramide in healthy probands]. [阿托品和甲氧氯普胺对健康先试者萨拉唑磺吡啶口服转运时间的影响]。
B Terhaag, A Neugebauer

The first appearance of sulpharyridine in plasma was investigated in nine healthy informed male volunteers. In a three way crossover design 6 g salazopyrin alone, together with metoclopramide (0.3 mg/kg i.m.) or atropine (0.01 mg/kg i.m.) were given. Sulphapyridine appears in the blood at the (means +/- S means) 6.2 h +/- 0.8 h (range: 3-11 h) in controls. Together with metoclopramide the first appearance is 3.6 h +/- 0.7 h (range: 2-8 h) and together with atropine these values are 8.1 +/- 0.8 h (range: 6-12 h). The differences are significant with p less than 0.05. The results show the pharmacological modification of motility in the gastrointestinal tract and in consequence the usefulness of salazopyridine to determine the transit time.

对9名健康男性志愿者首次出现的磺胺吡啶进行了调查。在三路交叉设计中,单独给予6 g萨拉唑吡林,与甲氧氯普胺(0.3 mg/kg i.m)或阿托品(0.01 mg/kg i.m)。在对照组中,磺胺吡啶在(平均值+/- S平均值)6.2 h +/- 0.8 h(范围:3-11 h)出现在血液中。甲氧氯普胺首次出现时间为3.6 h +/- 0.7 h(范围:2-8 h),阿托品首次出现时间为8.1 h +/- 0.8 h(范围:6-12 h), p < 0.05,差异有统计学意义。结果显示在胃肠道运动的药理学修饰,因此有用的萨拉唑吡啶来确定运输时间。
{"title":"[Modification of orocecal transit time of salazosulfapyridine by atropine and metoclopramide in healthy probands].","authors":"B Terhaag,&nbsp;A Neugebauer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The first appearance of sulpharyridine in plasma was investigated in nine healthy informed male volunteers. In a three way crossover design 6 g salazopyrin alone, together with metoclopramide (0.3 mg/kg i.m.) or atropine (0.01 mg/kg i.m.) were given. Sulphapyridine appears in the blood at the (means +/- S means) 6.2 h +/- 0.8 h (range: 3-11 h) in controls. Together with metoclopramide the first appearance is 3.6 h +/- 0.7 h (range: 2-8 h) and together with atropine these values are 8.1 +/- 0.8 h (range: 6-12 h). The differences are significant with p less than 0.05. The results show the pharmacological modification of motility in the gastrointestinal tract and in consequence the usefulness of salazopyridine to determine the transit time.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 6","pages":"327-32"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14018048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative in vitro studies of cell-mediated immunity in chronic liver diseases]. 慢性肝病细胞介导免疫的体外比较研究
B Königstedt, R Zipprich, R Nilius

Reactions of cell-mediated immunity are investigated in 32 healthy controls and 134 patients with chronic liver diseases (E-rosette-forming cells, lymphocyte transformation test, leucocyte migration inhibition test using the T-cell-mitogens Phytohaemagglutinin and Concanavalin A). The number of E-rosette-forming cells is significantly decreased in chronic active hepatitis, alcoholic hepatitis and cirrhosis. The 3H-thymidine uptake in the lymphocyte transformation test by use of PHA and Con A is markedly reduced especially in active and progressed liver diseases. PHA caused a significant higher inhibition of leucocyte migration in patients with alcoholic hepatitis and cirrhosis than in healthy controls. A dependency between the results of the two tests is not detectable (Chi 2-test). We found in individual cases of groups with liver diseases serum inhibition factors by MIT, but not correlations with other immunological or clinical-chemical parameters. The pathogenetical value of the used methods in cases with chronic liver diseases is questionable.

研究了32名健康对照者和134名慢性肝病患者的细胞介导免疫反应(e-玫瑰花形成细胞、淋巴细胞转化试验、使用t细胞有丝分裂原植物血凝素和豆豆蛋白A进行白细胞迁移抑制试验)。慢性活动性肝炎、酒精性肝炎和肝硬化患者的e-玫瑰花形成细胞数量明显减少。在使用PHA和Con A的淋巴细胞转化试验中,3h -胸腺嘧啶的摄取明显减少,特别是在活动性和进展性肝病中。PHA对酒精性肝炎和肝硬化患者白细胞迁移的抑制作用明显高于健康对照组。两个测试结果之间的依赖关系无法检测到(Chi - 2检验)。我们发现在肝病患者的个别病例中,血清抑制因子与MIT相关,但与其他免疫学或临床化学参数无关。在慢性肝病病例中使用的方法的致病价值是值得怀疑的。
{"title":"[Comparative in vitro studies of cell-mediated immunity in chronic liver diseases].","authors":"B Königstedt,&nbsp;R Zipprich,&nbsp;R Nilius","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Reactions of cell-mediated immunity are investigated in 32 healthy controls and 134 patients with chronic liver diseases (E-rosette-forming cells, lymphocyte transformation test, leucocyte migration inhibition test using the T-cell-mitogens Phytohaemagglutinin and Concanavalin A). The number of E-rosette-forming cells is significantly decreased in chronic active hepatitis, alcoholic hepatitis and cirrhosis. The 3H-thymidine uptake in the lymphocyte transformation test by use of PHA and Con A is markedly reduced especially in active and progressed liver diseases. PHA caused a significant higher inhibition of leucocyte migration in patients with alcoholic hepatitis and cirrhosis than in healthy controls. A dependency between the results of the two tests is not detectable (Chi 2-test). We found in individual cases of groups with liver diseases serum inhibition factors by MIT, but not correlations with other immunological or clinical-chemical parameters. The pathogenetical value of the used methods in cases with chronic liver diseases is questionable.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 2","pages":"113-21"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14611663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Results of small intestinal biopsy studies in childhood and their correlation to other paraclinical findings with special reference to celiac disease]. [儿童小肠活检研究结果及其与乳糜泻相关的其他临床旁发现的相关性]。
J Henker

From 1970 to 1983 1,000 successful peroral intestinal biopsies were carried out at the children's Hospital of the Medical Academy Dresden. No complications such as perforation or bleeding appeared. Peroral intestinal biopsy has a preeminent importance in the diagnostic of coeliac disease. Certain paraclinical parameters in children with coeliac disease were correlated with bioptically recordable small intestinal mucosa changes; from which following results and conclusions can be drawn: Neither reticulin nor gluten antibodies can be recommended as screening parameters for the peroral intestinal biopsy. The determination of reticulin antibodies is better suited for diet checking because of its greater specificity . During the acute phase of coeliac disease 50 per cent of the cases are to be expected to have decreased serum zinc levels. A short-term zinc substitution is to be recommended. An increased number of pathological EEG's can be found in children with coeliac disease; particularly after a longterm gluten-containing diet. Therefore gluten-provocation to diagnose a coeliac disease should be performed after the 6th year of life, this is after completion of the cerebral cell differentiation.

1970年至1983年,在德累斯顿医学院儿童医院进行了1 000例成功的肠道活检。无穿孔、出血等并发症。经口肠活检在乳糜泻的诊断中具有重要意义。乳糜泻患儿的某些临床旁参数与可记录的小肠黏膜变化相关;网状蛋白抗体和谷蛋白抗体均不能作为经口肠道活检的筛查参数。网状蛋白抗体的测定更适合于饮食检查,因为它具有更大的特异性。在乳糜泻的急性期,预计50%的病例血清锌水平下降。建议短期补锌。乳糜泻患儿病理性脑电图增多;尤其是在长期吃含谷蛋白的食物之后。因此麸质激发诊断乳糜泻应该在6岁以后进行,这是在脑细胞分化完成之后。
{"title":"[Results of small intestinal biopsy studies in childhood and their correlation to other paraclinical findings with special reference to celiac disease].","authors":"J Henker","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>From 1970 to 1983 1,000 successful peroral intestinal biopsies were carried out at the children's Hospital of the Medical Academy Dresden. No complications such as perforation or bleeding appeared. Peroral intestinal biopsy has a preeminent importance in the diagnostic of coeliac disease. Certain paraclinical parameters in children with coeliac disease were correlated with bioptically recordable small intestinal mucosa changes; from which following results and conclusions can be drawn: Neither reticulin nor gluten antibodies can be recommended as screening parameters for the peroral intestinal biopsy. The determination of reticulin antibodies is better suited for diet checking because of its greater specificity . During the acute phase of coeliac disease 50 per cent of the cases are to be expected to have decreased serum zinc levels. A short-term zinc substitution is to be recommended. An increased number of pathological EEG's can be found in children with coeliac disease; particularly after a longterm gluten-containing diet. Therefore gluten-provocation to diagnose a coeliac disease should be performed after the 6th year of life, this is after completion of the cerebral cell differentiation.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"46 5","pages":"282-6"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14921376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1